Redmile Group, LLC Pliant Therapeutics, Inc. Transaction History
Redmile Group, LLC
- $1.53 Billion
- Q2 2024
A detailed history of Redmile Group, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 3,209,591 shares of PLRX stock, worth $41.3 Million. This represents 2.25% of its overall portfolio holdings.
Number of Shares
3,209,591
Previous 3,097,220
3.63%
Holding current value
$41.3 Million
Previous $46.1 Million
25.23%
% of portfolio
2.25%
Previous 1.82%
Shares
15 transactions
Others Institutions Holding PLRX
# of Institutions
158Shares Held
63.8MCall Options Held
481KPut Options Held
105K-
Deep Track Capital, LP Greenwich, CT5.97MShares$76.9 Million2.11% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$64 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.6MShares$59.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$44.2 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN3.4MShares$43.8 Million3.33% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $627M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...